Flagship Pharmacodynamics & Safety Research
Submitted to Malaria Journal (Springer Nature)
In Vivo Modulation of Hepatic Cytochrome P450 Enzymes by Five Artemisinin-Based Combination Therapies in Wistar Rats
An experimental in vivo investigation systematically evaluating five widely deployed Artemisinin-Based Combination Therapies (ACTs): Dihydroartemisinin-Piperaquine (DHA-PQP), Artemisinin-Piperaquine (ART-PQP), Artesunate-Sulfadoxine/Pyrimethamine (AS+SP), Artemether-Lumefantrine (AL), and Artesunate-Amodiaquine (AA). Utilizing Modified Lowry microsomal protein normalization and Omura-Sato CO-difference spectroscopy, the study classifies net hepatic CYP450 inhibition and neutrality to guide safer polypharmacy in malaria-endemic populations.
DHA-PQP & ART-PQP
AS+SP, AL, & AA
Hepatic CYP450 Modulation
Drug-Drug Interaction Safety
AchivHealth Clinical Reference Archives
Applied regulatory monographs, clinical logistics frameworks, and digital care protocols developed in-house.
WHO AWaRe Antimicrobial Stewardship
Evidence-based prescribing guidance and resistance surveillance frameworks structured around WHO Access, Watch, and Reserve classifications.
Nigerian Controlled Drug Regulatory Frameworks
Compliance documentation covering controlled substance dispensing, audit trails, and NAFDAC and PCN regulatory reporting obligations.
Adult Vaccination Logistics
Cold-chain tracking, multi-dose schedule reconciliation, and immunization registry auditing for preventive adult health programs.
Telepharmacy Workflows
Digital consultation architecture, remote medication adherence follow-up, and structured patient-reported outcome capture.